BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 17342306)

  • 1. Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD10.
    Nagata S; Ajioka Y; Nishikura K; Watanabe G; Inoue T; Yamaguchi K; Watanabe H; Tanaka M; Tsuneyoshi M
    Oncol Rep; 2007 Apr; 17(4):721-9. PubMed ID: 17342306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenomas of the gallbladder. Morphologic features, expression of gastric and intestinal mucins, and incidence of high-grade dysplasia/carcinoma in situ and invasive carcinoma.
    Albores-Saavedra J; Chablé-Montero F; González-Romo MA; Ramírez Jaramillo M; Henson DE
    Hum Pathol; 2012 Sep; 43(9):1506-13. PubMed ID: 22386521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyloric gland adenoma: a histologic, immunohistochemical and molecular genetic study of 23 cases.
    Chlumská A; Waloschek T; Mukenšnabl P; Martínek P; Kašpírková J; Zámečník M
    Cesk Patol; 2015; 51(3):137-43. PubMed ID: 26421956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunohistochemical profile of the so-called bile duct adenoma: clues to pathogenesis.
    Hughes NR; Goodman ZD; Bhathal PS
    Am J Surg Pathol; 2010 Sep; 34(9):1312-8. PubMed ID: 20679879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia.
    Park DY; Srivastava A; Kim GH; Mino-Kenudson M; Deshpande V; Zukerberg LR; Song GA; Lauwers GY
    Am J Surg Pathol; 2008 Apr; 32(4):524-33. PubMed ID: 18300795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
    Adsay V; Jang KT; Roa JC; Dursun N; Ohike N; Bagci P; Basturk O; Bandyopadhyay S; Cheng JD; Sarmiento JM; Escalona OT; Goodman M; Kong SY; Terry P
    Am J Surg Pathol; 2012 Sep; 36(9):1279-301. PubMed ID: 22895264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations.
    Yamazaki K; Tajima Y; Makino R; Nishino N; Aoki S; Kato M; Sakamoto M; Morohara K; Kaetsu T; Kusano M
    World J Gastroenterol; 2006 Jun; 12(24):3803-9. PubMed ID: 16804962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal tubular adenoma of the pancreas, pyloric gland type: a clinicopathologic and immunohistochemical study of 6 cases.
    Nakayama Y; Inoue H; Hamada Y; Takeshita M; Iwasaki H; Maeshiro K; Iwanaga S; Tani H; Ryu S; Yasunami Y; Ikeda S
    Am J Surg Pathol; 2005 May; 29(5):607-16. PubMed ID: 15832084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade gastric adenomas/dysplasias: phenotypic expression, DNA ploidy pattern, and LOH at microsatellites linked to the APC gene.
    Tanaka A; Takemura-Tsukashita S; Kushima R; Sugihara H; Fujiyama Y; Hattori T
    Pathol Res Pract; 2008; 204(1):1-9. PubMed ID: 17964080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains.
    Shiroshita H; Watanabe H; Ajioka Y; Watanabe G; Nishikura K; Kitano S
    Pathol Int; 2004 May; 54(5):311-21. PubMed ID: 15086835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
    Takei K; Watanabe H; Itoi T; Saito T
    Pathol Int; 1996 Jun; 46(6):426-35. PubMed ID: 8869994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
    Takei K; Watanabe H; Itoi T; Saito T
    Pathol Int; 1996 Nov; 46(11):908-17. PubMed ID: 8970203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of an "intestinal marker" Cdx2 in pyloric gland adenoma of the gallbladder.
    Wani Y; Notohara K; Fujisawa M
    Virchows Arch; 2008 Nov; 453(5):521-7. PubMed ID: 18843504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?
    Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY
    Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenocarcinoma with pyloric gland phenotype of the extrahepatic bile ducts: a previously unrecognized and distinctive morphologic variant of extrahepatic bile duct carcinoma.
    Albores-Saavedra J; Chablé-Montero F; Méndez-Sánchez N; Mercado MÁ; Vilatoba-Chapa M; Henson DE
    Hum Pathol; 2012 Dec; 43(12):2292-8. PubMed ID: 22795356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyloric gland adenoma: an entity distinct from gastric foveolar type adenoma.
    Chen ZM; Scudiere JR; Abraham SC; Montgomery E
    Am J Surg Pathol; 2009 Feb; 33(2):186-93. PubMed ID: 18830123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyloric gland adenoma arising in Barrett's esophagus with mucin immunohistochemical and molecular cytogenetic evaluation.
    Kushima R; Vieth M; Mukaisho K; Sakai R; Okabe H; Hattori T; Neuhaus H; Borchard F; Stolte M
    Virchows Arch; 2005 May; 446(5):537-41. PubMed ID: 15838649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyloric gland adenoma-- how to diagnose?
    Vieth M; Vogel C; Kushima R; Borchard F; Stolte M
    Cesk Patol; 2006 Jan; 42(1):4-7. PubMed ID: 16506593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical mucin expression of short-segment Barrett's esophagus.
    Yamamoto S; Kijima H; Hara T; Kenmochi T; Kise Y; Tanaka H; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
    Tokai J Exp Clin Med; 2003 Jul; 28(2):57-63. PubMed ID: 14714830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.
    Kumagai R; Kohashi K; Takahashi S; Yamamoto H; Hirahashi M; Taguchi K; Nishiyama K; Oda Y
    World J Gastroenterol; 2015 Mar; 21(9):2700-10. PubMed ID: 25759539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.